Semaglutide and liraglutide, which were initially approved for the treatment of type 2 diabetes, have since been approved by the Food and Drug Administration as weight loss medications due to their effectiveness in promoting significant and sustained weight loss
PLoS ONE 19(12): e0309886
Minoxidil provides hair growth effects exclusively, while GHK-Cu offers systemic anti-aging, skin rejuvenation, and tissue repair benefits alongside hair restoration
Because, like it or not, its not going to go away.
Repurposing oncology-specific knowhow and insights regarding antigen selection, platform vector design, regulatory requirements and evolving trial design frameworks has supported movement beyond oncology indications
The Status Quo Prior to the Reform The MMDR review stage one discussion paper evaluated the status quo of the regulatory system as of 2014, as well as stakeholders understanding of the issues and desired future developments